F. & A. PHARMA-Handels-GmbH

About F. & A. PHARMA-Handels-GmbH

F. & A. PHARMA-Handels-GmbH is a German based innovative and dynamic pharmaceutical service provider, GDP- / ISO-certified, having main activities in distribution and warehousing of well-documented Active Pharmaceutical Ingredients (APIs), Excipients and Nutraceuticals, as well as service and consulting in the pharmaceutical sector.

  • DE
  • 2019
    On CPHI since
Contact info
  • Bonhoefferring 41, 46286, Dorsten, Germany

Products from F. & A. PHARMA-Handels-GmbH (3)

  • 5-Aminolevulinic acid (5-ALA)

    Product 5-Aminolevulinic acid (5-ALA)

    5-Aminolevulinic acid (also 5-ALA) an endogenous non-proteinogenic amino acid, is the first compound in the porphyrin synthesis pathway, the pathway that leads to heme in mammals and chlorophyll in plants. 
    5ALA is used in photodynamic detection and surgery of canc...
  • Apixaban

    Product Apixaban

    Apixaban, sold under the trade name Eliquis among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee replace...
  • Dabigatran etexilate

    Product Dabigatran etexilate

    Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Specifically it is used to prevent blood clots following hip or knee repla...

F. & A. PHARMA-Handels-GmbH Resources (1)

  • Brochure API Journal 2019

    As your partner for new API development projects F. & A. PHARMA is able to provide you with analytical samples, working standards, set of impurities, stability studies, ASMFs in European Format (CTD) or other appropriate documents for registration purposes. Most of our suppliers are specialised in the development of novel manufacturing processes, polymorphic forms and salts, which can be designed to ensure the non-infringement of patents through the application of alternative synthetic procedures. The early bird catches the worm !